CytoMed Therapeutics GDTC
NASDAQ GDTC
$0.84 +0.00 (+0.49%)
At close: Nov 11, 2026 · 4:00 PM EST

CytoMed Therapeutics (GDTC) Price to Book (2023 - 2026)

Updated

CytoMed Therapeutics' Price to Book was 2.26 in Q2 2026, down 37.2% from 3.60 a year earlier.

Analysis

CytoMed Therapeutics (GDTC) Price to Book (2023 - 2026) Analysis & Trends

For FY2025, Price to Book at CytoMed Therapeutics came in at 3.02, down 47.9% from FY2024.

  • In earlier years, Price to Book was 5.80 in FY2024 (-14.2%) and 6.75 in FY2023.
  • The Q2 2026 figure marks the lowest quarterly Price to Book since Q2 2023.
  • Compared with a year earlier, Price to Book was higher in 1 of the last four quarters, with an average decline of 12.5%.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 CytoMed Therapeutics 9.94 Mn -2.19 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.92
Dec 31, 2025 2.97
Jun 30, 2025 4.57
Dec 31, 2024 5.90
Jun 30, 2024 3.20
Dec 31, 2023 6.64
Jun 30, 2023 2.64
API Access

CytoMed Therapeutics Price to Book API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-book&ticker=GDTC&period=max&api_key=YOUR_API_KEY